FALCO HOLDINGS Co., Ltd.
Stock Price Chart
2026/07/16 UpdatedPrice Trend
2026/07/16 UpdatedPrice & Trading Details
2026/07/16 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/07/01Dividend History
Updated 2026/07/12| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥63 | -50.2% |
| 2025 | ¥126 | -7.0% |
| 2024 | ¥135 | +25.0% |
| 2023 | ¥108 | +58.8% |
| 2022 | ¥68 | - |
Financial Performance
2026/07/12 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥46,913M | ¥43,007M | ¥43,313M | ¥43,578M |
| Gross Profit | ¥14,644M | ¥12,923M | ¥13,357M | ¥13,811M |
| Operating Income | ¥3,076M | ¥2,153M | ¥2,335M | ¥2,498M |
| Pretax Income | ¥3,714M | ¥2,580M | ¥2,782M | ¥3,087M |
| Net Income | ¥2,261M | ¥1,666M | ¥1,920M | ¥2,016M |
| EPS | ¥214.03 | ¥150.90 | ¥180.81 | ¥200.06 |
| Operating Margin | 6.56% | 5.01% | 5.39% | 5.73% |
| Balance Sheet | ||||
| Total Assets | ¥38,893M | ¥36,425M | ¥36,019M | ¥36,863M |
| Total Equity | ¥26,589M | ¥26,024M | ¥25,252M | ¥25,868M |
| Total Liabilities | ¥12,304M | ¥10,401M | ¥10,767M | ¥10,995M |
| Cash | ¥12,603M | ¥10,065M | ¥9,420M | ¥9,267M |
| Interest-bearing Debt | ¥2,801M | ¥817M | ¥1,437M | ¥1,255M |
| Equity Ratio | 68.36% | 71.45% | 70.11% | 70.17% |
| D/E Ratio | 0.11 | 0.03 | 0.06 | 0.05 |
| Cash Flow | ||||
| Operating CF | ¥2,086M | ¥3,433M | ¥2,619M | ¥2,878M |
| Investing CF | ¥322M | -¥1,445M | -¥1,182M | -¥2,032M |
| Financing CF | -¥448M | -¥4,527M | -¥2,082M | -¥1,998M |
| Free CF | ¥708M | ¥2,192M | ¥1,132M | ¥1,285M |
| Efficiency | ||||
| ROE | 8.50% | 6.40% | 7.60% | 7.79% |
| ROA | 5.81% | 4.57% | 5.33% | 5.47% |
Latest IR Information
-
Notice Regarding Share Buyback
The acquisition consisted of 42,500 ordinary shares purchased on the market for a total of ¥1,083,320,100. The initial resolution set an upper limit of 300,000 shares and up to ¥8,000,000,000, with a period from 2026/05/25 to 2027/01/29. Cumulative total as...
Read more -
Notification Regarding the Disposal of Treasury Shares as Restricted Stock-Based Compensation
Read more -
[Falco Holdings] Notice Regarding Share Buyback｜June 2026
Falco Holdings Corporation acquired 12,500 shares of common stock through market purchase at the Tokyo Stock Exchange from May 25 to May 31, 2026, at a total cost of 31,703,500 yen. The company plans to continue acquiring up to 300,000...
Read more
Latest News (5 items)
Company Information
About
FALCO HOLDINGS Co., Ltd., a medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. The company offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, and microbiology; and genetic testing services. It also provides medical information technology services; and develops in vitro diagnostics for unmet medical needs. In addition, the company is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical chart systems, including HAYATE / NEO, a cloud-based electronic medical chart for small and medium-sized hospitals, as well as @home Dr., an electronic medical chart for bed less clinics. FALCO HOLDINGS Co., Ltd. was founded in 1962 and is headquartered in Osaka, Japan.
